Document is current
Any future updates will be listed below
-
Authors
Deng, Weiyue
Zhang, Yuying
Wang, Wei
Song, Aishi
Mukama, Omar
Huang, Jiarong
Han, Xiaobo
Deng, Sihao
Lin, Zuoxian
Habimana, Jean du Dieu
Huang, Rongqi
Peng, Kexin
Ni, Bing
Zhang, Shusheng
Yan, Xiaoxin
Li, Ji
Wu, Lin-Ping
Li, Zhiyuan
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (No.2019YFA0110500)
International Science and Technology Cooperation Program of Guangdong Province (No.2019A050510028)
Guangdong Pearl River Talents Program (No. 2017GC010411)
Frontier Research Programs of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (No. 2018GZR110105020)
Guangdong Provincial Natural Science Foundation (2021A1515010526)
Stem Cell New Drug, Innovation Hunan Team (2019RS1088)
2020 Hunan Province Key R&D Plan (2020SK2137)
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 29 September 2021
First Online: 21 October 2021
Declarations
:
: This study was conducted with approval from the Guangzhou Institute of Biomedicine and Health Ethics Committee. Written informed consent was obtained from the participant included in the study. All procedures performed in studies involving animals were conducted following the animal care and Use Committee of the Guangzhou Institute of Biomedicine and Health.
: Not applicable.
: The authors have no conflicting interests.
